Your browser doesn't support javascript.
loading
Cost-effectiveness analysis of pharmacogenomics-guided clopidogrel treatment in Spanish patients undergoing percutaneous coronary intervention.
Fragoulakis, Vasilios; Bartsakoulia, Marina; Díaz-Villamarín, Xando; Chalikiopoulou, Konstantina; Kehagia, Konstantina; Ramos, Jesús Gabriel Sánchez; Martínez-González, Luis Javier; Gkotsi, Maria; Katrali, Eva; Skoufas, Efthimios; Vozikis, Athanassios; John, Anne; Ali, Bassam R; Wordsworth, Sarah; Dávila-Fajardo, Cristina L; Katsila, Theodora; Patrinos, George P; Mitropoulou, Christina.
Afiliação
  • Fragoulakis V; The Golden Helix Foundation, London, UK.
  • Bartsakoulia M; Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece.
  • Díaz-Villamarín X; University of Granada, San Cecilio University Hospital, Granada, Spain.
  • Chalikiopoulou K; Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece.
  • Kehagia K; Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece.
  • Ramos JGS; Cardiología, hospital Universitario San Cecilio/hospital Campus de la Salud, Institute for biomedical research, ibs.GRANADA, Granada, Spain.
  • Martínez-González LJ; Genomics Unit, Centre for Genomics and Oncological Research (GENYO), University of Granada, Health Sciences Technology Park, Granada, Spain.
  • Gkotsi M; Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece.
  • Katrali E; Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece.
  • Skoufas E; Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece.
  • Vozikis A; Economics Department, University of Piraeus, Piraeus, Greece.
  • John A; Department of Pathology, United Arab Emirates University, College of Medicine and Health Sciences, Al-Ain, UAE.
  • Ali BR; Department of Pathology, United Arab Emirates University, College of Medicine and Health Sciences, Al-Ain, UAE.
  • Wordsworth S; Nuffield Department of Population Health, University of Oxford, Health Economics Research Centre, Oxford, UK.
  • Dávila-Fajardo CL; Oxford National Institute for Health Biomedical Research Centre, Oxford, UK.
  • Katsila T; University of Granada, San Cecilio University Hospital, Granada, Spain.
  • Patrinos GP; Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece.
  • Mitropoulou C; Department of Pharmacy, University of Patras School of Health Sciences, Patras, Greece. gpatrinos@upatras.gr.
Pharmacogenomics J ; 19(5): 438-445, 2019 10.
Article em En | MEDLINE | ID: mdl-30647444
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Inibidores da Agregação Plaquetária / Análise Custo-Benefício / Intervenção Coronária Percutânea / Clopidogrel Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Inibidores da Agregação Plaquetária / Análise Custo-Benefício / Intervenção Coronária Percutânea / Clopidogrel Tipo de estudo: Health_economic_evaluation / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Pharmacogenomics J Assunto da revista: BIOLOGIA MOLECULAR / FARMACOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido